202 related articles for article (PubMed ID: 30704674)
21. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
22. Targeted delivery of drugs to the brain.
Souto EB
Expert Opin Drug Deliv; 2013 Jul; 10(7):i-ii. PubMed ID: 23777459
[No Abstract] [Full Text] [Related]
23. Biodegradable polyanhydride-based nanomedicines for blood to brain drug delivery.
Brenza TM; Schlichtmann BW; Bhargavan B; Vela Ramirez JE; Nelson RD; Panthani MG; McMillan JM; Kalyanaraman B; Gendelman HE; Anantharam V; Kanthasamy AG; Mallapragada SK; Narasimhan B; Kanmogne GD
J Biomed Mater Res A; 2018 Nov; 106(11):2881-2890. PubMed ID: 30369055
[TBL] [Abstract][Full Text] [Related]
24. Multivalency in Drug Delivery-When Is It Too Much of a Good Thing?
Tjandra KC; Thordarson P
Bioconjug Chem; 2019 Mar; 30(3):503-514. PubMed ID: 30742420
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle transport across the blood brain barrier.
Grabrucker AM; Ruozi B; Belletti D; Pederzoli F; Forni F; Vandelli MA; Tosi G
Tissue Barriers; 2016; 4(1):e1153568. PubMed ID: 27141426
[TBL] [Abstract][Full Text] [Related]
26. Delivery of drugs to the brain via the blood brain barrier using colloidal carriers.
Tucker IG; Yang L; Mujoo H
J Microencapsul; 2012; 29(5):475-86. PubMed ID: 22563886
[TBL] [Abstract][Full Text] [Related]
27. Zein nanoparticles as vehicles for oral delivery purposes.
Irache JM; González-Navarro CJ
Nanomedicine (Lond); 2017 Jun; 12(11):1209-1211. PubMed ID: 28520512
[No Abstract] [Full Text] [Related]
28. Nanomedicine as a non-invasive strategy for drug delivery across the blood brain barrier.
Tam VH; Sosa C; Liu R; Yao N; Priestley RD
Int J Pharm; 2016 Dec; 515(1-2):331-342. PubMed ID: 27769885
[TBL] [Abstract][Full Text] [Related]
29. Targeting the brain--surmounting or bypassing the blood-brain barrier.
Potschka H
Handb Exp Pharmacol; 2010; (197):411-31. PubMed ID: 20217538
[TBL] [Abstract][Full Text] [Related]
30. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
Silva GA
Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
[TBL] [Abstract][Full Text] [Related]
31. The physics of drug-delivery across the blood-brain barrier.
Guiot C; Zullino S; Priano L; Cavalli R
Ther Deliv; 2016; 7(3):153-6. PubMed ID: 26893246
[No Abstract] [Full Text] [Related]
32. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
33. Accessing targeted nanoparticles to the brain: the vascular route.
Burkhart A; Azizi M; Thomsen MS; Thomsen LB; Moos T
Curr Med Chem; 2014; 21(36):4092-9. PubMed ID: 25039779
[TBL] [Abstract][Full Text] [Related]
34. BBB -on-a-chip to study nanoparticle transport.
Biotechnol Bioeng; 2017 May; 114(5):944. PubMed ID: 28324633
[No Abstract] [Full Text] [Related]
35. Aptamer Functionalization of Nanosystems for Glioblastoma Targeting through the Blood-Brain Barrier.
Monaco I; Camorani S; Colecchia D; Locatelli E; Calandro P; Oudin A; Niclou S; Arra C; Chiariello M; Cerchia L; Comes Franchini M
J Med Chem; 2017 May; 60(10):4510-4516. PubMed ID: 28471660
[TBL] [Abstract][Full Text] [Related]
36. Chitosan and chitosan coating nanoparticles for the treatment of brain disease.
Yu S; Xu X; Feng J; Liu M; Hu K
Int J Pharm; 2019 Apr; 560():282-293. PubMed ID: 30772458
[TBL] [Abstract][Full Text] [Related]
37. Apo E-Functionalization of Solid Lipid Nanoparticles Enhances Brain Drug Delivery: Uptake Mechanism and Transport Pathways.
Neves AR; Queiroz JF; Lima SAC; Reis S
Bioconjug Chem; 2017 Apr; 28(4):995-1004. PubMed ID: 28355061
[TBL] [Abstract][Full Text] [Related]
38. Internal benchmarking of a human blood-brain barrier cell model for screening of nanoparticle uptake and transcytosis.
Ragnaill MN; Brown M; Ye D; Bramini M; Callanan S; Lynch I; Dawson KA
Eur J Pharm Biopharm; 2011 Apr; 77(3):360-7. PubMed ID: 21236340
[TBL] [Abstract][Full Text] [Related]
39. Blood-brain barrier transport of drugs for the treatment of brain diseases.
Gabathuler R
CNS Neurol Disord Drug Targets; 2009 Jun; 8(3):195-204. PubMed ID: 19601817
[TBL] [Abstract][Full Text] [Related]
40. The 12th Conference on the Formulation and Delivery of Bioactives.
Tucker IG
Ther Deliv; 2010 Jul; 1(1):25-7. PubMed ID: 22816116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
